Stifel Nicolaus Raises Leidos (NYSE:LDOS) Price Target to $130.00

Share on StockTwits

Leidos (NYSE:LDOS) had its price objective increased by Stifel Nicolaus from $90.00 to $130.00 in a research report released on Thursday, The Fly reports. They currently have a hold rating on the aerospace company’s stock. The analysts noted that the move was a valuation call.

Several other research analysts have also recently issued reports on LDOS. Morgan Stanley raised their target price on Leidos from $90.00 to $98.00 and gave the stock an equal weight rating in a research report on Monday, December 23rd. Cowen reissued a buy rating and issued a $111.00 target price on shares of Leidos in a research report on Thursday, February 13th. Cfra cut Leidos from a buy rating to a hold rating in a research report on Wednesday, February 19th. SunTrust Banks raised their target price on Leidos from $117.00 to $135.00 and gave the stock a buy rating in a research report on Wednesday, February 19th. Finally, ValuEngine cut Leidos from a hold rating to a sell rating in a research report on Friday, January 3rd. One analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of Hold and a consensus target price of $101.50.

Shares of Leidos stock opened at $117.22 on Thursday. Leidos has a 52-week low of $61.74 and a 52-week high of $125.84. The stock’s 50-day simple moving average is $105.18 and its 200 day simple moving average is $91.68. The stock has a market capitalization of $16.58 billion, a P/E ratio of 25.54, a P/E/G ratio of 2.79 and a beta of 1.50. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.21 and a current ratio of 1.21.

Leidos (NYSE:LDOS) last announced its quarterly earnings data on Tuesday, February 18th. The aerospace company reported $1.51 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.35 by $0.16. Leidos had a return on equity of 22.51% and a net margin of 6.01%. The business had revenue of $2.95 billion for the quarter, compared to analysts’ expectations of $2.86 billion. During the same period in the previous year, the business posted $1.25 EPS. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. Equities research analysts forecast that Leidos will post 5.59 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 2nd. Stockholders of record on Monday, March 16th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.16%. The ex-dividend date of this dividend is Friday, March 13th. Leidos’s dividend payout ratio (DPR) is currently 26.31%.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Americana Partners LLC purchased a new position in Leidos during the 4th quarter valued at $28,000. Bartlett & Co. LLC acquired a new position in Leidos during the 3rd quarter valued at about $40,000. Firestone Capital Management acquired a new position in Leidos during the 4th quarter valued at about $40,000. NEXT Financial Group Inc increased its position in Leidos by 83.6% during the 4th quarter. NEXT Financial Group Inc now owns 426 shares of the aerospace company’s stock valued at $42,000 after buying an additional 194 shares in the last quarter. Finally, Solstein Capital LLC acquired a new position in Leidos during the 4th quarter valued at about $44,000. 76.09% of the stock is currently owned by hedge funds and other institutional investors.

About Leidos

Leidos Holdings, Inc provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.

Read More: Differences Between Momentum Investing and Long Term Investing

The Fly

Analyst Recommendations for Leidos (NYSE:LDOS)

Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.